Vita 34 AG Achieves Strongest Growth Since 2010
. - Revenues increase by 15 percent as compared to prior year to EUR 16.3 million - Profitability significantly increase…
. - Revenues increase by 15 percent as compared to prior year to EUR 16.3 million - Profitability significantly increase…
Vita 34 AG (WKN A0BL84), a pioneer in the field of the storage of stem cells from umbilical cord blood and tissue and a…
Vita 34 improves total operating revenue by about 22 percent to EUR 18.5 million compared to previous year Clearly incre…
. - Earnings before interest, taxes, depreciation and amortization (EBITDA) rises to EUR 1.5 million; high EBITDA margi…
. - Unique characteristic: Vita 34 is the only company in Germany that can store umbilical cord tissue along with umbil…
. - Successful increase in efficiency with a significant positive effect on group profits - Earnings before interest,…
VITA 34 AG (ISIN DE000A0BL849), the oldest private umbilical cord blood bank in the German-speaking countries, VITA 34 A…
. - Revenue and storages in period under review below last year's level - Increase in operating result in 1st half-yea…
VITA 34 AG (ISIN DE000A0BL849), the oldest private umbilical cord blood bank in the German-speaking countries, has succe…
The VITA 34 AG (ISIN DE000A0BL849), the oldest private umbilical cord blood bank in the German-speaking countries takes…